Fig. 3
Summary of the association between mtDNA haplogroups and CD4+ T cell recovery in HIV-infected patients who started combination antiretroviral therapy. Statistical: Logistic regression models were used to calculate the odds of higher or lower CD4+ recovery according to mtDNA haplogroups, one for each haplogroup evaluated. These regressions were adjusted by the most important clinical and epidemiological characteristics (gender, age, length of HIV-infection, baseline CD4+ cells/mm3, HIV transmission route, hepatitis C and hepatitis B coinfection, and cART regimen). aOR adjusted odds ratio, 95% CI 95% of confidence interval